News
Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...
Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems.
Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...
The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the ...
The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...
Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis ...
Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...
14h
Medical Device Network on MSNFDA approves Roche’s MET protein expression detecting assay for NSQ-NSCLCThe US Food and Drug Administration (FDA) has granted approval to Roche's VENTANA MET (SP44) RxDx Assay to help determine the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results